Noveome Biotherapeutics, Inc.

CIK 1478304 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Noveome Biotherapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 27, 2026D0001478304-26-000003
Aug 8, 2024D/A0001478304-24-000001
Aug 17, 2023D0001478304-23-000001
Oct 2, 2020D0001478304-20-000001
Apr 22, 2019D/A0001478304-19-000001
Jan 24, 2018D0001478304-18-000004
Apr 14, 2016D/A0001478304-16-000005
Jan 13, 2016D0001478304-16-000001
Jul 12, 2012D0001478304-12-000002